These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 16306876)
1. A twist for survival and cancer progression. Puisieux A; Valsesia-Wittmann S; Ansieau S Br J Cancer; 2006 Jan; 94(1):13-7. PubMed ID: 16306876 [TBL] [Abstract][Full Text] [Related]
2. [Cancer cells escape from failsafe programs in a simple Twist]. Puisieux A; Valsesia-Wittmann S Bull Cancer; 2006 Mar; 93(3):251-6. PubMed ID: 16567311 [TBL] [Abstract][Full Text] [Related]
3. [Inactivation of failsafe programs by Twist oncoproteins and tumor progression]. Puisieux A Ann Pharm Fr; 2008; 66(5-6):278-87. PubMed ID: 19061727 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966 [TBL] [Abstract][Full Text] [Related]
5. The Myc-nucleophosmin-ARF network: a complex web unveiled. Li Z; Hann SR Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540 [TBL] [Abstract][Full Text] [Related]
6. Twist is a potential oncogene that inhibits apoptosis. Maestro R; Dei Tos AP; Hamamori Y; Krasnokutsky S; Sartorelli V; Kedes L; Doglioni C; Beach DH; Hannon GJ Genes Dev; 1999 Sep; 13(17):2207-17. PubMed ID: 10485844 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787 [TBL] [Abstract][Full Text] [Related]
8. Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells. Feng MY; Wang K; Song HT; Yu HW; Qin Y; Shi QT; Geng JS Clin Exp Metastasis; 2009; 26(8):1013-23. PubMed ID: 19806464 [TBL] [Abstract][Full Text] [Related]
10. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Qing G; Li B; Vu A; Skuli N; Walton ZE; Liu X; Mayes PA; Wise DR; Thompson CB; Maris JM; Hogarty MD; Simon MC Cancer Cell; 2012 Nov; 22(5):631-44. PubMed ID: 23153536 [TBL] [Abstract][Full Text] [Related]
11. N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. Janardhanan R; Banik NL; Ray SK Biochem Pharmacol; 2009 Nov; 78(9):1105-14. PubMed ID: 19540207 [TBL] [Abstract][Full Text] [Related]
12. S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines. Ikegaki N; Hicks SL; Regan PL; Jacobs J; Jumbo AS; Leonhardt P; Rappaport EF; Tang XX Int J Oncol; 2014 Jan; 44(1):35-43. PubMed ID: 24173829 [TBL] [Abstract][Full Text] [Related]
13. Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Borriello A; Roberto R; Della Ragione F; Iolascon A Haematologica; 2002 Feb; 87(2):196-214. PubMed ID: 11836171 [TBL] [Abstract][Full Text] [Related]
14. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Boone DN; Qi Y; Li Z; Hann SR Proc Natl Acad Sci U S A; 2011 Jan; 108(2):632-7. PubMed ID: 21187408 [TBL] [Abstract][Full Text] [Related]
15. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Wallerand H; Robert G; Pasticier G; Ravaud A; Ballanger P; Reiter RE; Ferrière JM Urol Oncol; 2010; 28(5):473-9. PubMed ID: 19272800 [TBL] [Abstract][Full Text] [Related]
16. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma. Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555 [TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma. Regan PL; Jacobs J; Wang G; Torres J; Edo R; Friedmann J; Tang XX Int J Oncol; 2011 Jan; 38(1):105-12. PubMed ID: 21109931 [TBL] [Abstract][Full Text] [Related]
18. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740 [TBL] [Abstract][Full Text] [Related]
19. The ARF tumor suppressor: keeping Myc on a leash. Gregory MA; Qi Y; Hann SR Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352 [TBL] [Abstract][Full Text] [Related]
20. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma. Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]